OFFICIAL PUBLICATION OF

by its subsidiary APPco

Mixed news on tariffs

Guest Author 14/04/2025

Pharma not entirely insulated from Trump’s tariff plans despite an initial strong market reaction, says Mike Taylor It says a great deal about investor perceptions of the relative safety of the Australian pharmaceuticals sector in the wake of US President, Donald Trump’s initial, now partially stalled, tariff assault that seven out of 10 of the

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Pharmacy supply of vapes accelerates

Oh gosh, yet another "0.01% uptake" hot take. If the "more than 136,000" figure comes from the total number of…

Justin Levine

HMR safety: ‘What are we waiting for?’

The easiest way to facilitate a number of sticking points to HMR rules would be to allow say 10% of…

Vicki Dyson

HMR safety: ‘What are we waiting for?’

100% agree, I have had a few close calls over the years. Always make sure they don’t lock the front…

Gabrielle Davern

Pharmacy supply of vapes accelerates

So 136,000 vapes accessed through SAS in 18 months equates to 1900 od per week. Out of the approximately 2.5…

Nasis Ellis

Mixed news on tariffs

Previous Potential for AI ‘enormous’: pharmacist

Next Pharmacy fined over ‘alleged’ cannabis production

dRx series: Deprescribing teriparatide in older people

Contact dermatitis from daily skincare routines

dRx series: Deprescribing thyroxine in older people

dRx series: Deprescribing prednisone/prednisolone in older people

MENU

Previous Potential for AI ‘enormous’: pharmacist

Next Pharmacy fined over ‘alleged’ cannabis production

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.